Albendazole sulfoxide

Hazard statements (CLP)

H317, H361d, H373, H410

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Reproductive toxicity, (Category H361d: Suspected of damaging the unborn 2) child. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure if Adrenal gland, spleen, male swallowed. reproductive organs, Blood Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.

Signal word

Warning Warning

Hazard statements

H317 May cause an allergic skin reaction. H361d Suspected of damaging the unborn child. H373 May cause damage to organs (Adrenal gland, spleen, male reproductive organs, Blood) through prolonged or repeated exposure if swallowed. H410 Very toxic to aquatic life with long lasting effects. H317 May cause an allergic skin reaction. H361d Suspected of damaging the unborn child.

Precautionary statements

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Supplemental label elements

none Reduced Labeling (<= 125 ml) none

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.